Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

DPH 1,040.50 -14.50 (-1.37%)
price chart
Is AstraZeneca plc A Better Buy Than BTG plc, Dechra Pharmaceuticals plc And ...
Despite being in the midst of coming to terms with the loss of several key, blockbuster drugs, shares in AstraZeneca (LSE: AZN) (NYSE: AZN.
Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than ...
While shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have disappointed in the last year, it has not been the same story for a number of its pharmaceutical rivals. In fact, shares in Genus (LSE: GNS) and Dechra (LSE: DPH) have soared in the last 12 ...
3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and ...
However, I'm more interested in BTG and Dechra, which both occupy the FTSE 250 index. Yet BTG is around a ninth the size of Shire, and Dechra is around one thirty eighth the size of Shire, so we can pick from have a good spread of market capitalisations.
Dechra Pharmaceuticals plc Stock Rating Lowered by FinnCap (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) was downgraded by FinnCap to a “hold” rating in a research note issued on Tuesday.
Dechra Pharmaceuticals plc Receives Consensus Recommendation of "Hold ...  The Legacy
Dechra Pharmaceuticals plc Price Target Increased to GBX 1141 by Analysts at ...  sleekmoney
Dechra Pharmaceuticals plc PT Raised to GBX 1140 (DPH)
Dechra Pharmaceuticals plc logo Investment analysts at Jefferies Group hoisted their price objective on shares of Dechra Pharmaceuticals plc (LON:DPH) from GBX 950 ($14.42) to GBX 1,140 ($17.30) in a note issued to investors on Wednesday. The firm ...
Investec Raises Dechra Pharmaceuticals plc Price Target to GBX 1141 (DPH)  The Legacy
Dechra Pharmaceuticals plc Cut to "Hold" at FinnCap (DPH)  sleekmoney
Weekly Research Analysts' Ratings Changes for Dechra Pharmaceuticals plc ...
4/29/2015 - Dechra Pharmaceuticals plc had its price target raised by analysts at Jefferies Group from GBX 950 ($14.67) to GBX 1,140 ($17.61).
Northwich-based Dechra Pharmaceuticals PLC remains 'confident'
Competitor stock shortages in the US have meant strong revenues for Northwich-based Dechra Pharmaceuticals. The manufacturer of veterinary products has reported that group revenue has increased in this quarter by 14.3% at constant exchange rates and ...
Analysts Set Dechra Pharmaceuticals plc Target Price at $803.49 (LON:DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has been given a consensus rating of “Buy” by the three ratings firms that are presently covering the company, Stock Ratings News reports.
Dechra Pharmaceuticals plc Earns "Hold" Rating from N+1 Singer (DPH)
Analysts at Edison Investment Research reiterated a no rating system rating and set a GBX 955 ($14.38) price target on shares of Dechra Pharmaceuticals plc in a research note on Friday, February 27th. Analysts at Numis Securities Ltd downgraded shares ...
Recent Research Analysts' Ratings Updates for Dechra Pharmaceuticals plc ...
4/29/2015 - Dechra Pharmaceuticals plc had its price target raised by analysts at Jefferies Group from GBX 950 ($14.40) to GBX 1,140 ($17.28).